Sarcoma Disease Management Team, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2013 Jun;20(6):1851-7. doi: 10.1245/s10434-013-2876-y. Epub 2013 Jan 25.
Leiomyosarcoma is a soft tissue sarcoma whose outcome has historically been confounded by the inclusion of gastrointestinal stromal tumors. Thus, we sought to determine the factors that predict survival and recurrence in patients with primary leiomyosarcoma alone.
During 1982-2006, a total of 353 patients with primary resectable leiomyosarcoma were identified from a prospective database. Multivariate analysis was used to assess clinicopathologic factors for association with disease-specific survival (DSS). Competing risk survival analysis was used to determine factors predictive for local and distant recurrence.
Of 353 patients, 170 (48 %) presented with extremity, 144 (41 %) with abdominal/retroperitoneal, and 39 (11 %) with truncal tumors. Median age was 57 (range, 18-88) years, and median follow-up was 50 (range, 1-270) months. Most tumors were high grade (75 %), deep (73 %), and completely resected (97 %); median size was 6.0 (range, 0.3-45) cm. Abdominal/retroperitoneal location was associated with worse long-term DSS compared to extremity or trunk (P = 0.005). However, by multivariate analysis, only high grade and size were significant independent predictors of DSS. Overall, 139 patients (39 %) had recurrence: 51 % of those with abdominal/retroperitoneal, 33 % of extremity, and 26 % of truncal disease. Significant independent predictors for local recurrence were size and margin, whereas predictors for distant recurrence were size and grade. Site was not an independent predictor of recurrence; however, late recurrence (>5 years) occurred in 9 % of abdominal/retroperitoneal and 4 % of extremity lesions.
Grade and size are significant independent predictors of DSS and distant recurrence. Long-term follow-up in leiomyosarcoma is important, as late recurrence continues in 6-9 % patients.
平滑肌肉瘤是一种软组织肉瘤,其预后在历史上一直受到胃肠道间质瘤纳入的影响。因此,我们试图确定仅患有原发性平滑肌肉瘤的患者的生存和复发的预测因素。
在 1982 年至 2006 年期间,从一个前瞻性数据库中确定了 353 名患有原发性可切除平滑肌肉瘤的患者。使用多变量分析来评估与疾病特异性生存(DSS)相关的临床病理因素。使用竞争风险生存分析来确定预测局部和远处复发的因素。
在 353 名患者中,170 名(48%)表现为肢体,144 名(41%)表现为腹部/腹膜后,39 名(11%)表现为躯干肿瘤。中位年龄为 57 岁(范围,18-88 岁),中位随访时间为 50 个月(范围,1-270 个月)。大多数肿瘤为高级别(75%)、深(73%)和完全切除(97%);中位大小为 6.0cm(范围,0.3-45cm)。与肢体或躯干相比,腹部/腹膜后位置与长期 DSS 较差相关(P=0.005)。然而,通过多变量分析,只有高级别和大小是 DSS 的独立显著预测因素。总的来说,139 名患者(39%)有复发:51%的腹部/腹膜后肿瘤,33%的肢体肿瘤,26%的躯干肿瘤。局部复发的独立显著预测因素是大小和边缘,而远处复发的预测因素是大小和分级。部位不是复发的独立预测因素;然而,腹部/腹膜后病变中有 9%和肢体病变中有 4%发生了晚期复发(>5 年)。
分级和大小是 DSS 和远处复发的独立显著预测因素。平滑肌肉瘤的长期随访很重要,因为 6-9%的患者会出现迟发性复发。